![Andrew Partridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Partridge
Corporate Officer/Principal at
GRAIL, INC.
Net worth: 11 M $ as of 2026-06-29
Profile
Andrew Partridge is Chief Commercial Officer at GRAIL, Inc. since 2022.
Formerly, Mr. Partridge was Chief Commercial Officer & Executive VP at Turning Point Therapeutics, Inc. from 2020 to 2022, Chief Commercial Officer & Executive VP at Centrexion Therapeutics Corp.
from 2018 to 2020, VP & Head-North America Commercial Operations at Vertex Pharmaceuticals, Inc. from 2013 to 2018, and Executive Director-Sales & Oncology Business Unit at Amgen, Inc. from 2003 to 2013.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GRAIL INC 0.38% | 2026-06-03 | 163,738 ( 0.38% ) | 11 M $ | 2026-06-29 |
Andrew Partridge active positions
| Companies | Position | Start |
|---|---|---|
| GRAIL, INC. | Corporate Officer/Principal | 2022-04-30 |
Former positions of Andrew Partridge
| Companies | Position | End |
|---|---|---|
| TURG POIN | Corporate Officer/Principal | 2022-04-30 |
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | 2020-07-01 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2018-10-31 |
| AMGEN INC. | Sales & Marketing | 2012-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for chronic pain and autoimmune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
- Stock Market
- Insiders
- Andrew Partridge
